What We Test

Total cholesterol measures the overall amount of cholesterol circulating in the blood, encompassing both “good” (HDL) and “bad” (LDL and other) lipoprotein particles. Higher total cholesterol generally suggests a greater burden of atherogenic lipids and may indicate increased cardiovascular risk, while lower levels are typically associated with a more favorable risk profile. Levels can be influenced by diet high in saturated fats, lack of physical activity, genetic factors such as familial hypercholesterolemia, and certain medications like some diuretics or beta‑blockers. Because total cholesterol combines multiple lipoprotein fractions, it does not capture the full picture without considering HDL and LDL values.

Calcium is an essential mineral measured in blood that reflects the body’s bone health, muscle function, and cardiovascular signaling. Elevated calcium levels can suggest conditions such as hyperparathyroidism, excess vitamin D intake, or certain cancers, while low calcium may indicate deficiencies, vitamin D insufficiency, kidney disease, or malabsorption. Levels are influenced by dietary intake of calcium‑rich foods, supplement use, hormonal balance (especially parathyroid hormone), and renal function, as well as acute changes from dehydration or certain medications. Interpreting calcium results alongside other cardiometabolic markers helps clinicians assess overall metabolic status and guide appropriate lifestyle or medical interventions.

Lipoprotein(a) (Lp a) is a genetically determined cholesterol particle that carries an additional protein called apolipoprotein(a). Higher Lp a levels indicate a greater inherited risk for atherosclerotic cardiovascular disease, including heart attacks, aortic valve stenosis, and ischemic stroke, while lower levels suggest a comparatively lower genetic risk. Because the amount of Lp a is set largely by one’s genes, lifestyle factors such as diet, exercise, or weight have little impact, although overall cardiovascular health can modify the consequences of an elevated level. Family history, ethnicity, and certain hormonal changes (e.g., after menopause) can also influence measured concentrations.

Cholesterol/HDL ratio measures the amount of total cholesterol relative to high‑density lipoprotein (HDL) cholesterol, a marker of cardiometabolic health. A higher ratio generally indicates a larger proportion of potentially atherogenic cholesterol compared with protective HDL, suggesting increased cardiovascular risk, whereas a lower ratio reflects a more favorable balance and may be associated with better heart health. Factors that can raise the ratio include diets high in saturated fats, lack of physical activity, and certain medications, while regular exercise, weight management, and diets rich in unsaturated fats can help lower it. This metric is used for both men and women as part of cardiometabolic assessment.

Non‑HDL cholesterol is a laboratory metric that measures the total amount of atherogenic lipoproteins—essentially all cholesterol particles that can contribute to plaque buildup—by adding together LDL‑C, VLDL‑C, IDL‑C and other non‑HDL fractions. Higher non‑HDL levels generally suggest an increased risk for cardiovascular disease, while lower levels are associated with a more favorable lipid profile and reduced risk. Levels can be driven upward by factors such as a diet high in saturated fats, obesity, uncontrolled diabetes, or certain medications, and they may decrease with weight loss, regular physical activity, improved glycemic control, or lipid‑lowering therapies. This cardiometabolic biomarker helps clinicians assess overall atherogenic burden beyond LDL‑C alone.

Fasting glucose measures the concentration of glucose in the blood after an overnight fast and is a key cardiometabolic biomarker. Elevated fasting glucose can suggest impaired glucose regulation, early insulin resistance, or pre‑diabetes, while lower values generally reflect normal metabolic function, though excessively low levels may indicate hypoglycemia from medication, prolonged fasting, or endocrine disorders. Common factors that influence fasting glucose include recent dietary carbohydrate intake, physical activity levels, sleep quality, stress, and certain medications such as corticosteroids or insulin‑sensitizing agents. This lab metric, published and regularly updated, helps clinicians monitor metabolic health and guide lifestyle or therapeutic interventions when needed.

Homocysteine is an amino‑acid‑derived compound measured in blood that reflects one‑carbon metabolism and vascular health. Elevated levels can suggest increased cardiovascular risk, impaired vitamin B12 or folate status, and may be associated with kidney dysfunction, while lower levels are generally considered favorable and indicate adequate nutrient status. Common drivers of higher homocysteine include poor dietary intake of B‑vitamins, chronic inflammation, smoking, and certain medications such as methotrexate; regular physical activity and a diet rich in leafy greens, legumes, and fortified foods tend to support lower concentrations. This biomarker is categorized under cardiometabolic health and is part of the laboratory metrics panel.

Apolipoprotein B (ApoB) is a protein that marks each atherogenic lipoprotein particle circulating in the blood, serving as a direct count of “bad” cholesterol carriers. Higher ApoB levels indicate a greater number of these particles, suggesting increased risk for plaque buildup in arteries, while lower levels reflect fewer particles and a more favorable cardiovascular profile. Levels can rise with genetic predispositions such as familial hypercholesterolemia, poor dietary patterns high in saturated fats, obesity, or insufficient physical activity, and can be lowered through weight loss, healthier eating, regular exercise, and lipid‑lowering medications. This biomarker falls under the Cardiometabolic category.

Vitamin B12 is a water‑soluble vitamin essential for red blood cell formation, nerve health, and DNA synthesis. Higher levels generally indicate adequate dietary intake or supplementation, while lower levels may suggest deficiency that can lead to fatigue, nerve tingling, or anemia; deficiency is often driven by poor absorption due to gastrointestinal disorders, certain medications, or strict vegetarian diets. Elevated B12 can occasionally reflect liver disease, kidney dysfunction, or excessive supplementation, whereas low B12 may be seen in older adults, individuals with malabsorption syndromes, or those on long‑term proton‑pump inhibitors. This biomarker belongs to the cardiometabolic panel and is published for patient reference.

HDL cholesterol is a blood‑borne lipoprotein that helps clear excess cholesterol from arteries and transport it to the liver for disposal. Higher HDL levels are generally associated with better heart protection, while lower levels can indicate increased cardiovascular risk, especially when accompanied by factors such as insulin resistance, high triglycerides, obesity, or smoking. Lifestyle influences—regular aerobic exercise, weight loss, quitting tobacco, and consuming healthy fats—tend to raise HDL, whereas sedentary behavior, excess weight, and certain medications may lower it. This metric belongs to the cardiometabolic panel and is published for public reference.

Folate, also known as vitamin B9, is a water‑soluble vitamin that serves as a key co‑factor in DNA synthesis, red blood cell formation, and methylation pathways essential for cardiovascular and neurologic health. Higher folate levels generally indicate adequate nutritional intake and support of these physiological processes, whereas lower levels may suggest insufficient dietary intake, malabsorption, or increased metabolic demand, which can contribute to elevated homocysteine and associated cardiovascular risk. Common drivers of low folate include poor diet lacking leafy greens or fortified foods, chronic alcohol use, certain medications such as anticonvulsants, and conditions that impair absorption like celiac disease.

Triglycerides are a type of blood fat that reflects how the body stores and transports excess calories. Higher triglyceride levels often suggest increased cardiovascular risk and may signal metabolic disturbances such as obesity, insulin resistance, diabetes, high carbohydrate or alcohol intake, or certain medications, while lower levels generally indicate a healthier lipid profile and better metabolic balance. Levels can also rise temporarily after a fatty meal or during periods of physical inactivity, and they tend to be lower in individuals who maintain a balanced diet, regular exercise, and healthy weight. This biomarker belongs to the cardiometabolic panel and is used to assess overall heart‑disease risk.

Vitamin D (25‑hydroxyvitamin D) is a lab metric that measures the circulating form of vitamin D, reflecting overall vitamin D status in the body. Higher levels generally indicate adequate sun exposure, dietary intake, or supplementation and are associated with better bone health and immune function, whereas lower levels can suggest insufficient sunlight, poor dietary intake, malabsorption, obesity, certain medications, or chronic kidney disease, potentially leading to weakened bones and increased infection risk. Seasonal variation, geographic location, skin pigmentation, body weight, and use of vitamin D supplements are common factors that influence this biomarker.

LDL cholesterol is a blood measurement of low‑density lipoprotein particles that transport cholesterol to tissues. Higher LDL levels suggest a greater amount of “bad” cholesterol that can deposit in artery walls, increasing the risk of plaque buildup and cardiovascular events, while lower levels indicate reduced exposure and a more favorable heart‑health profile. Levels can rise with genetic conditions such as familial hypercholesterolemia, diets high in saturated fats, sedentary lifestyle, or certain medications, and may fall with long‑term healthy eating, regular exercise, weight control, or lipid‑lowering therapies. This biomarker belongs to the cardiometabolic category and is published as a lab metric.

Hemoglobin A1c (HbA1c) is a blood test that reflects average glucose exposure over the past two to three months by measuring the percentage of glycated hemoglobin. Higher A1c values suggest poorer long‑term blood sugar control and are associated with increased risk of diabetes complications, cardiovascular disease, and kidney problems, while lower values indicate better glucose management. Levels can be driven upward by chronic hyperglycemia, certain hemoglobin variants, or conditions that shorten red‑cell lifespan, and can appear lower in anemia, recent intensive therapy, or pregnancy. Because A1c integrates many days of glucose data, it offers a useful overview of metabolic health, though it may be less accurate in individuals with sickle cell disease or other hemoglobinopathies.

Magnesium is a mineral involved in hundreds of enzyme reactions, including muscle contraction, nerve signaling, blood pressure regulation, and energy production. A serum test measures the roughly 1 percent circulating in blood, while the remainder is stored in bone, muscle, and soft tissue. Because the body pulls from storage to keep blood levels steady, a normal result does not rule out depleted tissue stores. Low levels can cause cramps, tremors, and irregular heart rhythm, while high levels are uncommon outside of reduced kidney function or heavy supplement use.

Fasting insulin measures the hormone the pancreas releases to move glucose from the bloodstream into cells. Because insulin often rises years before blood sugar changes, it is one of the earliest available signals of insulin resistance and metabolic change. Higher levels typically reflect cells responding poorly to insulin, with the pancreas compensating by producing more, a pattern associated with excess body fat, inactivity, metabolic syndrome, and polycystic ovary syndrome. It is most informative when read alongside fasting glucose rather than on its own.

Immature granulocytes (IGs) are very early white‑blood‑cell precursors that normally reside in the bone marrow and appear only in trace amounts in peripheral blood. When IG levels are higher than the usual trace range, it can suggest that the bone marrow is releasing cells more rapidly, often due to infection, inflammation, physiological stress, or, less commonly, a hematologic disorder; lower or absent levels are typical in healthy individuals. Common drivers of elevated IGs include acute infections, systemic inflammation, intense physical stress, or certain medications that stimulate bone‑marrow activity. This biomarker is reported for females only and falls under the Immune & Inflammation category.

Plasma cells are a type of immune cell that produce antibodies and are normally confined to the bone marrow. Detecting them in peripheral blood is abnormal and may signal a plasma‑cell disorder such as multiple myeloma or, at higher levels, plasma‑cell leukemia. Elevated circulating plasma cells suggest an underlying disease process driving abnormal plasma‑cell proliferation, whereas very low or absent levels are expected in healthy individuals. Common drivers of increased plasma‑cell counts include malignant plasma‑cell neoplasms and, rarely, severe inflammatory or infectious conditions. This biomarker is male‑only, falls under the Immune & Inflammation category, and is reported in the “lab metric” panel.

Basophils (absolute and %) are a type of white blood cell measured in laboratory panels that reflect immune and inflammatory activity. Slightly higher basophil counts can suggest allergic reactions, chronic inflammation, or, less commonly, bone‑marrow disorders, while lower levels are generally not concerning and may simply reflect normal low baseline variability. Their numbers tend to rise during exposure to allergens, certain infections, or after taking medications such as antihistamines, and they can be modestly reduced by effective anti‑allergic treatment or resolution of an inflammatory episode. Because basophils normally constitute a very small fraction of leukocytes, any notable change should be interpreted in the broader clinical context.

Red Blood Cell Count (RBC) measures the number of red blood cells circulating in the blood, a key indicator of oxygen‑carrying capacity and overall hematologic health. Higher RBC levels can suggest dehydration, chronic low‑oxygen conditions such as living at high altitude, or, less commonly, polycythemia, while lower levels may indicate anemia from blood loss, nutritional deficiencies, reduced bone‑marrow production, or hemolysis. Common drivers of variation include recent illness, intense physical training, hydration status, and certain medications that affect marrow function. As an immune‑and‑inflammation panel metric, RBC should be interpreted alongside related measures like hemoglobin and hematocrit for a fuller picture.

Hematocrit measures the proportion of red blood cells in the total blood volume, indicating how much of the blood is made up of these oxygen‑carrying cells. Higher hematocrit levels can suggest dehydration, living at high altitude, chronic low‑oxygen conditions, or true polycythemia, while lower levels often reflect anemia, blood loss, or reduced red‑cell production. Common factors that influence hematocrit include fluid balance—where inadequate hydration raises the value—and underlying health conditions such as kidney disease, nutritional deficiencies, or chronic inflammatory states that can lower it. Because the metric varies between men and women, reference ranges differ by sex, and interpretation should consider these physiological differences.

Hemoglobin is a protein in red blood cells that carries oxygen throughout the body. Higher hemoglobin levels can suggest dehydration, chronic low‑oxygen conditions, or, less commonly, disorders such as polycythemia, while lower levels often indicate anemia caused by iron, vitamin B12 or folate deficiency, blood loss, chronic disease, hemolysis, or bone‑marrow problems. Common drivers of variation include nutritional status, recent bleeding, chronic illnesses, and hydration level. This biomarker belongs to the “Immune & Inflammation” category and is measured in standard laboratory panels. It is applicable to all adults, with typical reference ranges differing slightly between men and women.

Eosinophils (absolute and %) are a type of white‑blood cell measured in blood panels that reflect immune and inflammation activity. Higher eosinophil levels often indicate allergic conditions, atopic disorders, or a parasitic infection, while markedly elevated counts can also appear with certain medication reactions or less common systemic diseases; lower levels are usually seen with stress, recent steroid use, or acute illness and are generally not worrisome. Common drivers of elevation include seasonal allergies, asthma, and exposure to helminths, whereas reductions are frequently linked to cortisol‑mediated stress responses or short‑term corticosteroid therapy.

Reactive lymphocytes are a type of white‑blood‑cell that become activated and change shape during an active immune response. Higher numbers usually indicate that the body is fighting a recent viral infection, reacting to a vaccine, or responding to certain medications, while low or absent levels are typical in healthy individuals and suggest no acute immune challenge. Common drivers of increased reactive lymphocytes include viral illnesses such as influenza or Epstein‑Barr virus, recent immunizations, and drug‑induced immune stimulation. Because they reflect a temporary, appropriate immune activation, their presence alone does not imply malignancy or chronic disease.

Serum iron measures the amount of iron bound to transferrin that is circulating in the blood at a given moment. Higher serum‑iron levels can suggest recent iron intake, supplementation, hemolysis, or liver disease, while lower levels may indicate iron deficiency, chronic inflammation, or chronic disease states. Levels can fluctuate with meals, inflammation, and daily rhythms, so a single measurement is best interpreted alongside other iron‑related tests such as ferritin, transferrin saturation, and total iron‑binding capacity. Because it is influenced by dietary iron and inflammatory status, clinicians consider recent food intake and any underlying illness when evaluating the result.

Metamyelocytes are immature neutrophil precursors that normally reside in the bone marrow and are absent from the peripheral blood of healthy adults. Their presence in a blood sample indicates a pronounced left shift, suggesting that the marrow is releasing cells early, which can occur during severe infections, marked inflammation, significant physiological stress, or hematologic disorders. Elevated levels therefore point to an active or overwhelming immune response or marrow stress, while low or absent levels are typical for a stable, healthy state. Common drivers of increased metamyelocytes include acute bacterial infections, systemic inflammatory conditions, and bone‑marrow‑affecting diseases.

Neutrophils (absolute and %) are a laboratory measurement that quantifies the number and proportion of neutrophil white‑blood cells circulating in your blood. Higher neutrophil counts, known as neutrophilia, often suggest the body is responding to bacterial infection, inflammation, physical stress, or exposure to certain medications such as steroids; lower counts, called neutropenia, can occur with viral infections, some drugs, chemotherapy, or bone‑marrow disorders and may increase infection risk. Common drivers of variation include acute illness, recent surgery, intense exercise, and medication effects, while chronic conditions or immune‑system disorders can also influence results.

Ferritin is the body’s primary iron‑storage protein, reflecting total iron reserves. Higher ferritin levels can indicate excess iron, inflammation, liver disease, alcohol use, or metabolic dysfunction, while lower levels suggest depleted iron stores and possible iron‑deficiency anemia. Common drivers of elevated ferritin include acute or chronic inflammation and liver injury, whereas low ferritin often results from inadequate dietary iron, increased physiological demand, or chronic blood loss. Because reference ranges differ by sex—generally higher in men than women—interpretation should consider gender‑specific norms. Overall, ferritin provides a useful snapshot of iron status but must be evaluated in the context of other clinical factors.

Red Cell Distribution Width (RDW) is a laboratory metric that quantifies the variation in size among a person’s red blood cells. Higher RDW values suggest greater diversity in cell size, which can indicate underlying physiologic stress such as inflammation, oxidative damage, or suboptimal nutrient status, and have been linked to increased cardiovascular risk and overall mortality; lower values generally reflect more uniform cell size and a healthier hematologic profile. Common drivers of elevated RDW include chronic illnesses, nutritional deficiencies (e.g., iron, B‑12, folate), and inflammatory conditions, while acute blood loss or recent transfusion may also affect results.

Prolymphocytes are immature‑appearing lymphoid cells that are normally absent or present in only trace amounts in peripheral blood. An elevated proportion of prolymphocytes suggests a possible lymphoid malignancy, especially when accompanied by lymphocytosis, whereas low or undetectable levels are typical for healthy individuals. Increases are commonly driven by underlying blood cancers such as chronic lymphocytic leukemia or prolymphocytic leukemia, while transient rises are rare and usually reflect serious hematologic disorders rather than lifestyle factors. Because they are a morphological finding, interpretation requires expert hematologic review rather than self‑directed action.

Lymphocytes are a type of white‑blood cell that serve as the primary coordinators of the body’s targeted immune response, comprising roughly one‑third of circulating white cells. Higher lymphocyte counts (lymphocytosis) often suggest an active viral infection such as the flu or mononucleosis, and can also be seen in certain blood cancers like chronic lymphocytic leukemia; lower counts (lymphopenia) may indicate conditions such as HIV infection, autoimmune disorders, or the effects of chemotherapy. Levels can fluctuate with acute illness, immune system stress, or medication use, reflecting overall immune activity rather than a specific diagnosis.

Myelocytes are immature neutrophil precursors that normally reside in the bone marrow and are not present in peripheral blood. When they appear in a blood sample, it suggests a pronounced left shift, indicating that the bone marrow is releasing cells earlier than usual. Higher levels can signal strong marrow stimulation caused by acute infections, significant inflammation, severe physiological stress, or a myeloproliferative disorder, whereas lower or absent levels are typical in healthy individuals. Common drivers of elevated myelocytes include bacterial sepsis, intense inflammatory conditions, and certain hematologic diseases that push the marrow to produce and release cells rapidly.

Mean Corpuscular Volume (MCV) measures the average size of red blood cells. Higher MCV values indicate larger red cells, which can suggest deficiencies in vitamin B12 or folate, chronic alcohol use, certain medications, or bone‑marrow disorders, while lower MCV values reflect smaller red cells often seen with iron deficiency, thalassemia, or chronic disease. Common drivers of elevated MCV include poor nutrition, excessive alcohol intake, and drugs that affect DNA synthesis; reduced MCV frequently results from inadequate iron intake, gastrointestinal blood loss, or inherited hemoglobin disorders. Changes in MCV help clinicians categorize anemia types and guide further evaluation.

Promyelocytes are very early granulocyte precursor cells normally found only in the bone marrow; their presence in peripheral blood is abnormal. Elevated levels suggest significant bone‑marrow stress or disruption, such as acute leukemia, severe infection, or toxic injury, whereas low or absent levels are expected in healthy individuals. Common drivers of increased promyelocytes include marrow infiltration by malignant cells, high‑grade infections, or exposure to certain chemotherapy agents, while reductions simply reflect normal marrow function. Because they are not sex‑specific, this marker applies to all patients, and any detection warrants further hematologic evaluation.

Blasts are immature blood‑forming cells that are normally confined to the bone marrow, with virtually no presence in peripheral blood under healthy conditions. Elevated blast counts in circulation indicate that the bone marrow is releasing these precursor cells abnormally, which often points to a marrow disorder such as leukemia or severe marrow stress; low or absent levels are typical and expected. Common drivers of increased blasts include hematologic malignancies, severe infections, or exposure to certain chemotherapeutic agents that disrupt normal marrow function. Because blasts are not a sex‑specific marker, the interpretation applies equally to all patients.

Mean Corpuscular Hemoglobin (MCH) measures the average amount of hemoglobin contained in each red blood cell. Higher MCH values generally indicate larger red cells that carry more hemoglobin, which can occur in conditions such as vitamin B12 or folate deficiency, while lower MCH values suggest smaller, less hemoglobin‑rich cells often seen with iron deficiency anemia or thalassemia. Common drivers of these changes include nutritional deficiencies (iron, B12, folate), chronic blood loss, or genetic hemoglobin disorders. The metric is part of a lab panel focused on immune and inflammation assessment and is applicable to all adults without sex‑specific interpretation.

Mean Corpuscular Hemoglobin Concentration (MCHC) measures how densely hemoglobin is packed inside each red blood cell, indicating the concentration of hemoglobin per cell. Lower MCHC values usually suggest reduced hemoglobin content, most often seen in iron‑deficiency anemia or thalassemia, while higher values are less common and can point to structural abnormalities of red cells such as hereditary spherocytosis. Factors that influence MCHC include iron status, chronic disease, and certain genetic conditions that affect red‑cell production or shape. Because it reflects cell‑level hemoglobin rather than total blood volume, MCHC helps clinicians characterize the type of anemia present.

Mean Platelet Volume (MPV) measures the average size of platelets, the blood cells that help form clots. Larger (higher) MPVs usually indicate younger, more active platelets, which can suggest increased platelet production or activation and may be seen in conditions such as smoking, hypertension, diabetes, or heightened cardiovascular risk, reflecting a more pro‑thrombotic state. Smaller (lower) MPVs often correspond to older, less reactive platelets and can appear during inflammatory illnesses, infections, or bone‑marrow suppression. MPV should be interpreted together with platelet count and overall clinical context rather than used alone to diagnose or predict outcomes.

Band neutrophils are immature white‑blood cells measured as part of a differential blood count, indicating the early stage of neutrophil development. Higher percentages suggest the body is rapidly producing neutrophils, often seen during acute bacterial infections, intense physical stress, certain medications, or early bone‑marrow activation, reflecting an active immune response. Lower levels generally indicate a stable, non‑inflamed state with fewer immature cells circulating, which is typical in healthy individuals. Common drivers of elevated band neutrophils include infections, vigorous exercise, and stressors that stimulate the bone marrow, while reductions are usually seen when the immune system is not under acute challenge.

Platelet Count measures the number of circulating platelets, a key component of blood clotting and vascular repair. Higher platelet levels can indicate reactive processes such as inflammation, infection, iron deficiency, or, less commonly, bone‑marrow disorders, while lower levels suggest reduced clotting ability and a greater risk of bleeding, often due to bone‑marrow suppression, certain medications, or autoimmune conditions. Common drivers of elevated counts include acute inflammatory states or recent surgery, whereas decreased counts may arise from viral infections, chemotherapy, or immune‑mediated platelet destruction. This biomarker falls under the Immune & Inflammation category and is part of the lab metric panel.

The Complete Blood Count (CBC) is a laboratory panel that measures the numbers and characteristics of red blood cells, white blood cells, and platelets in a single blood sample. Higher or lower values of these components can suggest different health states: elevated white‑cell counts often point to infection, inflammation, or stress, while low counts may indicate bone‑marrow suppression or certain immune disorders; increased red‑cell or hemoglobin levels can reflect dehydration or polycythemia, whereas low levels are typical of anemia; platelet counts that are high may signal inflammation or a reactive process, and low counts can increase bleeding risk. Common drivers of CBC variations include acute infections, chronic inflammatory conditions, recent intense exercise, dehydration, and medications such as steroids or chemotherapy. The panel provides a broad snapshot of hematologic and immune health without diagnosing a specific disease.

High‑Sensitivity C‑Reactive Protein (hs‑CRP) is a blood‑based marker that quantifies low‑grade inflammation produced by the liver. Elevated hs‑CRP levels suggest increased chronic inflammation, which is linked to higher cardiovascular risk, whereas lower levels indicate a relatively quiescent inflammatory state. Common drivers of higher hs‑CRP include acute infections, injuries, obesity, smoking, and sedentary lifestyle, while regular exercise, weight loss, anti‑inflammatory diets, and smoking cessation can help keep it lower. The test does not require fasting and is stable throughout the day, making it a practical tool for ongoing risk assessment.

Nucleated Red Blood Cells (NRBCs) are immature red blood cell precursors that normally reside only in the bone marrow and are absent from the peripheral blood of healthy adults. Their presence in a blood sample indicates that the bone marrow is releasing cells prematurely, which can suggest significant physiologic stress such as severe anemia, low oxygen levels, hemolysis, major infection, marrow infiltration, or critical illness. Higher NRBC counts generally reflect greater stress or damage to the hematopoietic system, while lower or absent levels are typical for healthy individuals. Common drivers of elevated NRBCs include acute blood loss, hypoxic conditions, and serious infections, all of which prompt the marrow to accelerate red cell production.

Total Iron Binding Capacity (TIBC) measures the maximum amount of iron that blood proteins, primarily transferrin, can carry when fully saturated. Higher TIBC values typically suggest iron deficiency, as the body produces more transferrin to capture scarce iron, while lower values can indicate inflammation, liver disease, malnutrition, or iron overload where transferrin production is reduced. Common drivers of elevated TIBC include inadequate dietary iron intake or chronic blood loss, whereas reduced TIBC often accompanies acute-phase inflammatory responses or chronic liver conditions. Interpreting TIBC alongside ferritin, serum iron, and transferrin saturation provides a clearer picture of iron status.

Iron Saturation (%) measures the proportion of transferrin binding sites that are occupied by iron, indicating how much iron is readily available for the body’s use. Lower values suggest insufficient iron for red blood cell production and may point to iron deficiency, chronic inflammation, or conditions that limit iron absorption, while higher values can indicate excess iron storage or overload, which may occur with repeated transfusions or certain genetic disorders. Common drivers of low saturation include dietary iron shortage, gastrointestinal blood loss, or inflammatory states that sequester iron, whereas elevated levels are often seen in hemochromatosis or excessive supplementation. This biomarker belongs to the Immune & Inflammation panel and helps clinicians assess iron availability beyond serum iron alone.

White Blood Cell Count (WBC) is a lab metric that measures the total number of immune cells circulating in the blood, serving as a broad indicator of immune system activity. Higher WBC levels can suggest the presence of infection, inflammation, stress, smoking, or exposure to steroids, while lower levels may reflect viral illness, certain medications, autoimmune conditions, or bone‑marrow suppression. Common drivers of elevated counts include acute bacterial infections and intense physical stress, whereas reduced counts often occur during viral infections or after chemotherapy. Interpreting the result requires considering recent illnesses, lifestyle factors, and any medications that might affect white‑cell production.

Monocytes are a type of white‑blood cell that act as versatile cleanup agents, accounting for roughly 3–8 % of circulating leukocytes and briefly patrolling the bloodstream before migrating into tissues where they become macrophages that engulf bacteria, dead cells and debris. Elevated monocyte counts (monocytosis) can suggest chronic infections such as tuberculosis, ongoing inflammatory conditions, or certain hematologic disorders, while reduced levels are generally less clinically significant and often reflect a transient shift in immune activity rather than a specific disease. Common drivers of higher monocytes include persistent infections, inflammatory stress, and some medications, whereas lower counts may occur during acute stress responses or after intensive corticosteroid therapy.

Platelet estimation is a microscopic review of platelets on a peripheral blood smear that provides a visual check on the automated platelet count. Higher estimated platelet numbers suggest thrombocytosis, which can be seen with inflammation, iron deficiency, or myeloproliferative disorders, while lower estimates indicate thrombocytopenia, often caused by platelet clumping, giant platelets, or consumption in bleeding or bone‑marrow problems. Results are influenced by sample handling—EDTA‑induced clumping can falsely lower counts, and using a citrate tube may resolve apparent low values. The assessment helps clarify unexpected automated results and guides further evaluation.

Aspartate aminotransferase (AST/SGOT) is an enzyme found primarily in liver cells, as well as in heart, muscle, and kidneys, that helps convert amino acids into energy. Elevated AST levels often suggest liver injury or inflammation, such as from viral hepatitis, fatty liver disease, or medication‑induced damage, while lower‑than‑normal values are generally not clinically concerning. Conversely, reduced AST may be seen in severe malnutrition or advanced liver failure when the organ can no longer produce the enzyme. Common factors influencing AST include alcohol consumption, certain drugs (e.g., statins, acetaminophen), intense exercise, and muscle trauma, all of which can temporarily raise the enzyme in the bloodstream.

Alkaline phosphatase is an enzyme found in several tissues, most notably the liver, bone, kidney and bile ducts, and it is measured as part of routine liver and digestion panels. Elevated levels can suggest increased bone turnover, liver disease, bile‑duct obstruction, or certain infections, while lower levels may be seen in malnutrition, vitamin B6 deficiency, or after certain genetic conditions. Common factors that influence its concentration include recent bone growth or healing, liver inflammation, pregnancy, and use of medications such as anticonvulsants or oral contraceptives. Interpreting the result alongside other liver‑function tests and clinical context helps clarify whether the change reflects normal variation or an underlying health issue.

Globulin is a group of blood proteins that includes antibodies and carrier proteins involved in immune function, inflammation, and transport of hormones, lipids, and metals. Higher globulin levels can suggest increased immune activity, chronic inflammation, infections, or certain liver conditions, while lower levels may indicate reduced immune protein production, protein loss, or severe liver disease. Common drivers of elevated globulin include persistent infections, autoimmune disorders, and inflammatory states, whereas reductions can be seen with malnutrition, kidney disease, or protein‑losing conditions. Interpretation should consider overall health, medication use, and other laboratory findings.

The Albumin / Globulin Ratio is a calculated laboratory metric that compares the amount of albumin, the main protein made by the liver, to the total globulins, a group of proteins involved in immune function and transport. A higher ratio generally suggests relatively more albumin than globulins, which can indicate good liver synthetic capacity and lower inflammatory activity, whereas a lower ratio may point to reduced albumin production, increased globulin levels, or both—situations often seen with chronic liver disease, malnutrition, or persistent inflammation. Common factors that influence this ratio include liver health, nutritional status, acute or chronic infections, and certain medications that affect protein synthesis or immune activity.

Alanine aminotransferase (ALT/SGPT) is an enzyme measured in blood that reflects liver cell health and function. Elevated ALT levels often suggest liver inflammation or injury caused by conditions such as viral hepatitis, fatty liver disease, alcohol use, or certain medications, while lower-than‑usual levels are generally not concerning and may simply reflect normal variation. Conversely, persistently low ALT does not typically indicate a problem. Factors that can raise ALT include acute infections, metabolic syndrome, and recent strenuous exercise, whereas adequate hydration and avoidance of hepatotoxic drugs can help maintain typical values. This biomarker belongs to the liver & digestion category and is part of lab metric panels.

Total Protein measures the combined amount of albumin, globulins, and other proteins circulating in the blood, reflecting overall protein synthesis and nutritional status. Higher levels can suggest dehydration, chronic inflammation, or conditions such as multiple myeloma, while lower levels may indicate liver disease, malnutrition, or protein‑losing kidney disorders. Common factors influencing these values include recent illness, dietary protein intake, and certain medications that affect liver function or fluid balance. Because Total Protein is a broad marker, it is interpreted alongside other liver and digestion panel tests to help clinicians assess the body’s protein balance and related health status.

Albumin is a protein made by the liver that helps maintain fluid balance in the bloodstream and transports various substances. Higher albumin levels generally indicate good nutritional status and healthy liver function, while lower levels can suggest liver disease, kidney problems, malnutrition, or inflammation. Common factors that influence albumin include chronic illnesses such as cirrhosis or nephrotic syndrome, acute infections, and severe dehydration, which can artificially raise concentrations. Medications that affect liver metabolism or protein synthesis may also alter albumin values, and changes should be interpreted in the context of overall clinical assessment.

Total Bilirubin is a laboratory measurement that quantifies the amount of bilirubin, a yellow pigment produced from the breakdown of red blood cells, present in the blood. Elevated bilirubin levels can suggest the liver is having difficulty processing or excreting bilirubin, which may occur in conditions such as hepatitis, bile duct obstruction, or hemolysis, while unusually low levels are generally less concerning but may be seen in rare genetic disorders affecting bilirubin production. Factors that influence bilirubin concentrations include liver function, the rate of red blood cell turnover, certain medications, and fasting or dehydration, all of which can alter the balance of bilirubin generation and clearance.

Glucose (Urine) is a laboratory measurement that detects the presence of glucose in a urine sample, indicating that blood glucose levels have surpassed the kidney’s reabsorption capacity. Higher urine glucose typically suggests elevated blood sugar, which can occur in conditions such as diabetes, impaired glucose tolerance, or during acute stress or infection that raises glucose temporarily; lower or absent levels are expected in healthy individuals with normal glucose regulation. Factors that can increase urinary glucose include uncontrolled diabetes, certain medications (e.g., corticosteroids), and high carbohydrate intake, while dehydration or low blood glucose may reduce its detection. This metric belongs to the Kidney & Urinary panel and is not sex‑specific.

Urine pH measures how acidic or alkaline the urine is, reflecting the balance of acids and bases processed by the kidneys and influenced by diet and metabolism. Lower (more acidic) values can suggest a high‑protein diet, metabolic acidosis, or conditions that increase acid production, while higher (more alkaline) values may indicate a urease‑producing urinary‑tract infection, renal tubular acidosis, or a diet rich in fruits and vegetables; both extremes can affect stone formation, with acidic urine favoring uric acid or cystine stones and alkaline urine favoring calcium phosphate or struvite stones. Common drivers include dietary composition, hydration status, and certain medications, and persistent deviations may warrant further clinical evaluation.

Protein (Urine) is a laboratory measurement that detects the presence of protein in the urine, indicating how effectively the kidneys filter blood. Higher levels, known as proteinuria, can suggest early kidney stress, vascular changes, or metabolic strain, while very low or absent protein is normal and reflects healthy filtration. Persistent elevations may be driven by conditions such as hypertension, diabetes, dehydration, intense exercise, or certain medications, whereas temporary spikes can occur after illness or strenuous activity and usually resolve. This metric falls under the Kidney & Urinary category and is part of the lab metric panel.

Ketones in urine are small molecules that appear when the body burns fat for energy instead of glucose, often during fasting, low‑carbohydrate diets, or certain illnesses. Higher concentrations can suggest that carbohydrate stores are low or that the body is under metabolic stress, while very low or absent levels are typical for most well‑fed individuals. Elevated urinary ketones may also be seen in uncontrolled diabetes, where they can signal a risk of diabetic ketoacidosis, whereas modest amounts in healthy people are usually harmless and reflect recent dietary choices. Common drivers include prolonged fasting, very low‑carb eating patterns, illness, and high blood sugar levels.

Urine color is a visual indicator of urine concentration and overall hydration status, ranging from clear to dark amber. Lighter shades generally suggest adequate fluid intake, while darker colors can indicate dehydration or concentrated urine; however, very pale urine may sometimes reflect over‑hydration or dilution. Common factors that influence urine color include fluid consumption, dietary components, medications, and certain health conditions—red urine can result from blood, hemoglobin, myoglobin, or specific foods/drugs, whereas brown urine may signal liver disease or myoglobin release, orange urine often reflects dehydration or medication effects, and black or purple hues are rare and may point to metabolic or infectious causes. This metric is not sex‑specific and should be interpreted alongside other clinical information.

Blood Urea Nitrogen (BUN) is a laboratory metric that measures the amount of urea nitrogen in the blood, reflecting the balance between protein breakdown and kidney excretion. Higher BUN levels can suggest dehydration, reduced kidney blood flow, high protein intake, or catabolic states such as illness or intense physical stress, while lower levels may indicate liver disease, malnutrition, or over‑hydration. Common factors influencing BUN include fluid status, dietary protein, and underlying kidney or liver conditions. This marker is part of the Kidney & Urinary panel and is useful for assessing renal function in conjunction with creatinine.

Granular casts are microscopic kidney‑derived particles seen on urine microscopy that consist of fragmented cells and protein debris. Their presence usually indicates that the kidneys are under stress or irritation, often seen in conditions such as acute kidney injury, chronic kidney disease, or severe dehydration; lower or absent levels are typical in healthy individuals. Higher levels can suggest impaired filtration or inflammatory processes within the kidney, while fewer or no casts generally reflect normal renal function. Common drivers include acute illness, volume depletion, certain medications, and advanced kidney disease, all of which may increase the likelihood of detecting granular casts in a urine sample.

Hyaline casts are microscopic protein structures that form in the kidney tubules and appear in urine when the urine becomes more concentrated or the kidney’s filtering process is mildly stressed. Higher numbers of hyaline casts can suggest dehydration, intense exercise, or temporary physiological stress, whereas lower or absent levels are typical for healthy kidneys. Common drivers of increased hyaline casts include inadequate fluid intake, vigorous physical activity, and mild systemic stressors such as fever or low‑grade illness; they are generally considered normal findings when only a few are present and do not indicate serious kidney disease in otherwise healthy individuals.

Nitrites are a urinary biomarker that indicates the presence of nitrate‑reducing bacteria, most commonly Escherichia coli, in the urinary tract. A positive nitrite test suggests a bacterial urinary tract infection because these organisms convert urinary nitrates to nitrites, whereas a negative result does not rule out infection due to its lower sensitivity. Higher nitrite levels typically point to an active infection, while low or absent nitrites are common in healthy individuals or when non‑nitrate‑reducing organisms are present. Factors that can affect results include frequent urination, which may reduce bladder dwell time, and the presence of bacteria that do not reduce nitrate.

Chloride is an electrolyte that works alongside sodium to help maintain fluid balance and acid‑base status in the body. Elevated chloride levels can suggest dehydration, excess salt intake, or conditions that cause metabolic acidosis, while low levels may indicate over‑hydration, certain kidney disorders, or loss of stomach acids. Common factors that influence chloride include fluid intake, renal function, and medications such as diuretics or corticosteroids. In clinical practice chloride is interpreted as part of a comprehensive metabolic panel rather than in isolation, providing insight into overall electrolyte and acid‑base homeostasis.

Potassium is an essential electrolyte that helps regulate the electrical activity of heart muscle and the function of nerves and other muscles throughout the body. When potassium levels are lower than usual, it can lead to muscle weakness, fatigue, and abnormal heart rhythms, often seen in conditions such as chronic kidney disease, excessive sweating, or use of certain diuretics; higher-than‑normal levels may also disrupt heart rhythm and become dangerous, commonly occurring with kidney impairment, tissue breakdown, or medications that reduce potassium excretion. Maintaining stable potassium is especially important for individuals with kidney or urinary disorders, as they are more susceptible to these fluctuations.

Urine clarity is a visual assessment of how transparent the urine appears, indicating the presence or absence of substances that can cloud it. Clear urine generally reflects adequate hydration and normal kidney function, while cloudy urine can suggest factors such as urinary tract infection, the presence of crystals from alkaline urine, or contamination from cells, mucus, or sperm; these findings are not always pathologic but should be interpreted in context. Common drivers of cloudiness include recent infections, dietary influences that affect urine pH, and dehydration, as well as physiological contributions like seminal fluid in males. Interpretation should consider overall health, medication use, and recent activities.

Urine Specific Gravity measures the concentration of solutes in urine, indicating how well the kidneys are concentrating fluid. Higher values suggest dehydration, excess glucose in urine, or reduced water intake, while lower values may reflect overhydration, diabetes insipidus, or impaired kidney concentrating ability. Common factors influencing this metric include fluid consumption, illness that causes vomiting or diarrhea, and certain medications such as diuretics. In healthy individuals, the result primarily mirrors hydration status, and persistent deviations can point to underlying renal or endocrine issues that may require further evaluation.

Urobilinogen is a metabolite produced when gut bacteria break down bilirubin, and a small amount is normally found in urine. Higher urinary urobilinogen levels can indicate increased bilirubin turnover due to hemolysis or impaired liver function, while low or absent levels may suggest a blockage in the bile ducts that prevents bilirubin from reaching the intestines. Common factors that influence urobilinogen concentrations include liver diseases such as hepatitis or cirrhosis, conditions that cause rapid red‑blood‑cell breakdown, and certain medications that affect bilirubin metabolism. This kidney‑related biomarker is part of laboratory metric panels and helps clinicians assess hepatic and biliary health.

Leukocyte esterase is an enzymatic marker that indicates the presence of white blood cells in urine, signaling possible urinary tract inflammation or infection. Higher levels suggest pyuria, which can be caused by urinary tract infections, kidney stones, or other inflammatory conditions, while lower or absent levels are typical in healthy individuals without urinary pathology. Results can be affected by contamination of the sample, recent antibiotic use, high urinary glucose or protein, and intake of vitamin C, all of which may mask or falsely elevate the enzyme’s detection. Interpretation should always consider clinical symptoms and other urine findings.

Estimated Glomerular Filtration Rate (eGFR) is a laboratory metric that estimates how well the kidneys are filtering blood. Higher eGFR values generally indicate better kidney function, while lower values suggest reduced filtration capacity and may reflect underlying kidney disease or acute injury. Levels can be influenced by factors such as age, muscle mass, hydration status, and certain medications that affect creatinine production or clearance. Because eGFR is calculated from serum creatinine, changes in creatinine due to diet, intense exercise, or muscle disorders can also affect the result. Monitoring trends over time provides a clearer picture of kidney health than a single measurement.

White Blood Cells (Urine) is a laboratory metric that measures the number of white blood cells present in a urine sample, indicating inflammation in the urinary tract. Higher levels typically suggest that the immune system is responding to irritation or infection somewhere along the urinary system, most commonly a bladder infection (UTI) or, less frequently, kidney involvement; lower or absent levels are normal and reflect a healthy urinary tract. Common drivers of elevated results include bacterial infections, inflammatory conditions, or recent catheter use, while dehydration or certain medications can affect the concentration of cells in the sample.

Crystals are microscopic solid particles that can appear in urine when certain substances become concentrated. Higher amounts of crystals may suggest an increased risk for kidney stones or underlying metabolic disturbances, while lower or absent levels are generally typical and often harmless. Common drivers of crystal formation include dehydration, which concentrates urine, and dietary factors such as high intake of oxalate‑rich foods or excess calcium; certain medical conditions like hyperparathyroidism or urinary infections can also promote crystal presence. In healthy individuals occasional crystals are normal, but persistent or specific types may warrant further evaluation.

Blood (Urine) is a laboratory metric that detects the presence of red blood cells, hemoglobin, or myoglobin in urine, indicating hematuria. Higher levels, visible as gross blood or confirmed by microscopy, suggest bleeding from the urinary tract or kidneys and may be associated with conditions such as kidney disease, urinary stones, infections, or malignancy; lower or absent levels are typical in healthy individuals. Common drivers of elevated results include recent vigorous exercise, menstruation, sexual activity, or acute infections, which can cause transient discoloration. Persistent or recurrent findings warrant repeat testing and further evaluation to determine the source and significance of the bleeding.

Epithelial Cells (Urine) are microscopic cells that line the urinary tract and are detected in a urine laboratory panel. Higher numbers of these cells, especially kidney‑derived types, can suggest irritation, inflammation, or injury to the kidneys or urinary system, whereas lower or occasional squamous cells are usually harmless and often reflect normal shedding from the skin or genital area. Common drivers of increased epithelial cells include urinary tract infections, kidney stones, recent catheter use, or vigorous exercise that stresses the kidneys, while adequate hydration and the absence of infection typically keep levels low.

Sodium is an essential electrolyte that helps regulate fluid balance and nerve function throughout the body. Higher sodium levels often suggest dehydration, excessive salt intake, or conditions that cause water loss such as diarrhea or certain medications, while lower levels can indicate over‑hydration, kidney problems, or hormonal imbalances that cause excess water relative to sodium. Common drivers of sodium fluctuations include changes in fluid intake, use of diuretics or antihypertensive drugs, and acute illnesses that affect water loss or retention. Because sodium is a key component of kidney‑related panels, monitoring its trends can aid in understanding overall hydration status and kidney health.

Carbon Dioxide (Bicarbonate) measures the concentration of bicarbonate ions in the blood, a key component of the body’s acid‑base buffering system that helps keep pH stable. Higher bicarbonate levels can suggest excess base, compensation for chronic lung disease, or metabolic alkalosis, while lower levels may indicate acid buildup (acidosis), kidney dysfunction, or loss of bicarbonate through diarrhea. Common drivers of abnormal results include respiratory disorders, renal impairment, certain medications (e.g., diuretics), and severe dehydration. Because bicarbonate reflects overall metabolic balance, interpreting it alongside other labs provides a clearer picture of a patient’s health status.

Bacteria in urine is a laboratory metric that detects the presence of microorganisms in a urine sample. Higher bacterial counts typically suggest a urinary tract infection, especially when accompanied by symptoms such as pain, urgency, or fever, whereas low or absent bacteria often indicate a clean sample or possible contamination without infection. Common drivers of increased bacterial levels include poor hygiene, catheter use, or recent sexual activity, while factors like adequate hydration and proper sample collection can reduce false‑positive results. Interpretation should always consider the patient’s symptoms and may be confirmed with a urine culture when needed.

The BUN / Creatinine Ratio is a laboratory metric that compares blood urea nitrogen to creatinine to help assess kidney function and fluid status. A higher ratio often suggests reduced kidney perfusion due to factors such as dehydration, catabolism, or gastrointestinal bleeding, whereas a lower ratio may indicate intrinsic kidney injury or over‑hydration. These changes should be interpreted within the broader clinical context, including the patient’s overall health, medication use, and acute illnesses, as the ratio alone has limited reliability for distinguishing specific types of acute kidney injury.

Red Blood Cells (Urine) is a laboratory metric that measures the presence of red blood cells in a urine sample, indicating whether blood is leaking into the urinary tract. Higher levels suggest bleeding anywhere along the urinary system, which can arise from benign causes such as vigorous exercise or minor irritation, as well as more significant conditions like kidney stones, urinary‑tract infections, or, less commonly, tumors; lower or absent levels are typical in healthy individuals. Common drivers of elevated results include recent strenuous activity, dehydration, certain medications, and underlying renal or urinary pathology. This metric is not sex‑specific and should be interpreted alongside clinical context and repeat testing when persistent.

Red Blood Cell Casts are microscopic tubular structures seen in urine that contain intact red blood cells, indicating they formed within the kidney’s collecting system. Their presence typically signals bleeding that originates from the kidney itself and is often linked to inflammatory kidney conditions such as glomerulonephritis or acute tubular injury; higher levels suggest more active or severe renal pathology, whereas their absence is expected in healthy individuals. Common drivers for their formation include infections, autoimmune diseases, and certain medications that affect renal vasculature or inflammation. This biomarker is not sex‑specific and is reported under the Kidney & Urinary panel.

Bilirubin (Urine) measures the amount of bilirubin, a breakdown product of red blood cells, that appears in the urine. Detectable bilirubin is considered abnormal and may indicate that the liver is not processing bilirubin efficiently or that there is a blockage in the bile ducts, while absence of bilirubin is typical for healthy individuals. Common causes of elevated urinary bilirubin include liver diseases such as hepatitis or cirrhosis, bile duct obstruction, and increased red cell breakdown from hemolysis or certain medications.

Creatinine is a waste product generated from normal muscle metabolism and cleared by the kidneys, making it a common laboratory marker of kidney function. Higher creatinine levels usually indicate reduced kidney filtration ability, while lower levels often reflect normal kidney function but can also occur in individuals with low muscle mass, such as the elderly or those with poor nutrition. Common factors that influence creatinine include muscle mass (higher in men and athletes) and kidney‑affecting conditions like diabetes, hypertension, or certain medications. Because creatinine production varies by sex and body composition, interpreting the result alongside other clinical information is essential.

A urinalysis examines urine for signs of kidney disease, diabetes, urinary tract infection, and liver problems. It is a single test producing around a dozen results across three groups: physical characteristics like color, clarity, and concentration, chemical findings from a reagent strip including protein, glucose, ketones, blood, and nitrites, and a microscopic examination for cells, bacteria, crystals, and casts. Individual findings matter less than the patterns they form together, and many results are benign or reflect hydration and collection technique rather than disease.

Microalbumin measures small amounts of albumin leaking into the urine, one of the earliest detectable signs of kidney stress. The test reports albumin alongside urine creatinine and combines them into the albumin-creatinine ratio, which corrects for how dilute the sample is. A ratio between 30 and 300 mg/g indicates moderately increased excretion, an early warning window most commonly linked to diabetes and high blood pressure that can appear years before kidney function measurably declines. It is also an independent marker of cardiovascular risk.

Thyroid‑Stimulating Hormone (TSH) is a pituitary‑derived hormone that regulates thyroid gland activity and overall metabolic rate. Higher TSH levels typically indicate that the thyroid is under‑active (hypothyroidism), suggesting the body is signaling for more thyroid hormone production, while lower TSH levels often reflect an over‑active thyroid (hyperthyroidism) where less stimulation is needed. Common factors that can raise TSH include iodine deficiency, autoimmune thyroid disease, and certain medications such as lithium, whereas acute illness, pregnancy, and high‑dose thyroid hormone therapy can suppress TSH. Interpretation should consider the clinical context and any concurrent conditions that affect thyroid function.

Sex Hormone Binding Globulin (SHBG) is a protein that binds to sex hormones, primarily testosterone, regulating their availability in the bloodstream. Higher SHBG levels can reduce the amount of free, active testosterone, potentially contributing to symptoms such as reduced libido, fatigue, or muscle weakness, while lower levels may increase free testosterone, which can be associated with conditions like acne, hair loss, or an elevated risk of prostate issues. Levels are influenced by factors such as age, liver function, thyroid status, obesity, insulin resistance, and certain medications (e.g., hormonal therapies or anticonvulsants). This biomarker is reported for males only.

Total Testosterone (male‑only) is the primary androgen hormone measured in the bloodstream of men, reflecting overall androgen status. Higher levels can indicate robust gonadal function, vigorous muscle building, or anabolic steroid use, while lower levels may suggest hypogonadism, aging‑related decline, chronic illness, or medication effects such as opioids. Common drivers of variation include age, body composition, acute stress, sleep quality, and certain health conditions like obesity, diabetes, or thyroid disorders. Because this biomarker is specific to males, interpretation focuses on male physiological norms and the impact of lifestyle or medical factors on testosterone production.

Follicle Stimulating Hormone (FSH) is a hormone that helps regulate the reproductive system by stimulating the growth of ovarian follicles in females and supporting sperm production in males. Higher FSH levels can suggest reduced ovarian reserve or menopause in women, and potential testicular dysfunction in men, while lower levels may indicate hypothalamic or pituitary disorders affecting hormone signaling. Levels can be influenced by age, hormonal medications, and certain health conditions such as polycystic ovary syndrome or pituitary tumors. This biomarker belongs to the Hormones & Reproductive panel and is used in clinical assessments of fertility and endocrine health.

Luteinizing Hormone (LH) is a pituitary‑derived hormone that regulates the function of the gonads in both males and females, playing a key role in ovulation and testosterone production. Elevated LH levels can suggest conditions such as polycystic ovary syndrome, menopause transition, or pituitary disorders, while low levels may indicate hypogonadism, pituitary insufficiency, or stress‑related suppression. Levels naturally fluctuate with the menstrual cycle in women and with age in both sexes, and they can be influenced by factors like acute illness, certain medications (e.g., hormonal contraceptives or dopamine antagonists), and intense physical stress.

Free Testosterone (male‑only) is a lab metric that measures the unbound fraction of testosterone circulating in the blood, representing the biologically active hormone available to tissues. In men, higher free testosterone levels generally suggest robust androgen activity, supporting muscle mass, libido, and overall vitality, whereas lower levels can indicate hypogonadism, chronic illness, aging, or the impact of certain medications such as steroids or opioids. Common drivers of variation include age‑related hormonal decline, obesity, high‑intensity training, sleep deprivation, and conditions like thyroid disorders or pituitary dysfunction. This hormone metric is specific to males and is categorized under Hormones & Reproductive.

Bioavailable testosterone measures the portion of testosterone that is not tightly bound to sex hormone–binding globulin, representing the hormone that can actually reach androgen receptors in tissues; it is a male‑only metric. Higher bioavailable levels generally indicate greater androgen activity, which may be seen in younger men, those with low SHBG, or after resistance training, while lower levels suggest reduced hormonal action and can be associated with symptoms such as fatigue, low libido, or muscle loss. Common drivers of low bioavailable testosterone include elevated SHBG from aging, obesity, thyroid disorders, liver disease, or medications that increase SHBG, whereas high levels may occur when SHBG is low, during acute exercise, or with certain supplements.

Prostate‑Specific Antigen (PSA) is a protein made by the prostate gland that circulates in the blood of men. Higher PSA values can indicate prostate cancer, benign enlargement, inflammation, recent ejaculation, infection, or vigorous cycling, while lower values are generally reassuring but can be artificially reduced by obesity or certain medications such as 5‑alpha‑reductase inhibitors. PSA trends over time, density (adjusted for prostate size), and velocity (rate of change) provide additional context beyond a single result. Because PSA is male‑only, its interpretation must consider age, family history, ethnicity, and any recent activities that might transiently raise the level.

Estradiol (E2) is the most potent form of estrogen and the primary female sex hormone, measured in blood to assess reproductive and overall health; it is a female‑only marker. Higher estradiol levels can indicate ovarian activity such as a normal mid‑cycle surge, use of estrogen‑containing medications, obesity‑related aromatization, or estrogen‑producing tumors, while lower levels may signal menopause, premature ovarian insufficiency, stress‑related hypothalamic suppression, or certain pituitary disorders. Levels fluctuate throughout the menstrual cycle, so timing of the draw (early follicular, mid‑cycle, luteal) and factors like age, cycle phase, hormonal therapies, and body weight shape the interpretation.

Thyroid peroxidase (TPO) antibodies are immune proteins that target an enzyme the thyroid uses to produce hormones. Their presence is the most common marker of autoimmune thyroid disease and often appears years before thyroid function itself changes. A positive result is the defining finding in Hashimoto's thyroiditis and is also common in Graves' disease, but it does not mean the thyroid is currently malfunctioning. Many people have detectable antibodies with normal TSH and Free T4, which signals higher future risk and a reason to monitor rather than treat.

Prolactin is the pituitary hormone best known for driving milk production, but it also suppresses the hormones that trigger ovulation. Elevated levels are a common and often treatable cause of irregular or absent periods, difficulty conceiving, and milk production unrelated to nursing. Frequent causes include certain medications, hypothyroidism, significant stress, and benign pituitary tumors. Levels peak during sleep and fluctuate through the day, so a morning draw gives the most reliable reading, and mild elevations are often transient and rechecked before being acted on.

Progesterone is the hormone released after ovulation that prepares the uterine lining for a possible pregnancy. Because levels rise and fall sharply across the menstrual cycle, the timing of the blood draw matters more than for almost any other hormone, with a peak around seven days after ovulation. Low levels during the expected luteal peak can suggest ovulation did not occur or that production is inadequate, which is relevant to irregular cycles and difficulty conceiving. Low levels are expected after menopause, and high levels are most commonly explained by pregnancy.

DHEA-S (dehydroepiandrosterone sulfate) is an adrenal hormone that serves as a precursor to testosterone and estrogen, making it a marker of adrenal androgen output. Levels peak in the twenties and decline steadily with age, so results are interpreted against age as well as sex. Higher levels can reflect increased adrenal androgen production and are evaluated in women with irregular cycles, acne, or excess hair growth. Lower levels are commonly a normal consequence of aging but can also reflect reduced adrenal function or long-term corticosteroid use.

Free T4 (free thyroxine) measures the unbound portion of thyroxine circulating in the blood, the fraction available to enter tissues and act on cells. The thyroid gland produces mostly T4, making it the primary output of thyroid function. Higher levels can suggest an overactive thyroid or over-replacement with thyroid medication, while lower levels may point to an underactive thyroid or under-replacement. Free T4 is measured alongside TSH to assess overall thyroid function.

Active Calories is a smart‑metric that estimates the energy you expend through movement such as walking, exercise, and daily activities, separate from your resting metabolic needs. Higher values generally indicate more physical activity and can suggest good adherence to activity guidelines, while lower values may reflect sedentary behavior, recovery periods, or limited mobility. Daily totals are influenced by factors like workout intensity, step count, heart‑rate variability, and personal characteristics such as age, weight, and gender. Device algorithms (e.g., Apple Watch) use heart‑rate and motion sensors, so variations in sensor accuracy, medication that affects heart rate, or illness can also affect the reading.

Active Minutes is a smart metric that quantifies the amount of time a person spends moving at a level above sedentary throughout the day. Higher active‑minute totals generally suggest greater overall physical activity, which can be associated with improved cardiovascular health, better metabolic function, and enhanced mood, while lower totals may indicate a more sedentary lifestyle that can contribute to weight gain, reduced fitness, and increased risk of chronic conditions. Common drivers of active‑minute counts include daily habits such as walking, exercise routines, occupational movement, and lifestyle factors like sleep quality and stress levels; changes in workload, health status, or medication side effects can also influence how much activity is recorded.

Awake Time (WASO), short for Wake After Sleep Onset, is a smart metric that measures the total amount of time spent awake after first falling asleep, including brief arousals and longer awakenings through the night. Lower values indicate more consolidated, uninterrupted sleep, while higher values point to fragmented rest that can reduce sleep efficiency and leave a person feeling unrested even after enough time in bed. Common drivers of increased awake time include stress, alcohol, caffeine, an uncomfortable or noisy environment, needing to use the bathroom overnight, sleep disorders such as sleep apnea, and the natural increase in nighttime awakenings with age. Captured by a wearable, it is most useful as a trend and is not sex-specific.

Body Mass Index (BMI) is a simple, widely used metric that estimates body fat based on an individual’s height and weight. Higher BMI values generally suggest increased body mass relative to height, which can be associated with greater risk for cardiovascular disease, type 2 diabetes, and other metabolic conditions, while lower values may indicate underweight status and potential concerns such as nutrient deficiency or frailty. Factors that commonly influence BMI include diet quality, physical activity levels, and underlying health conditions or medications that affect weight. Because BMI does not differentiate between muscle and fat, it should be interpreted alongside other clinical information for a more complete assessment.

Body Fat Percentage is a smart metric that estimates the proportion of fat relative to total body mass. Higher values generally indicate greater adiposity, which can be associated with increased cardiometabolic risk, while lower values suggest a leaner physique and potentially better metabolic health, though extremely low levels may signal undernutrition or hormonal disturbances. Factors influencing this metric include diet quality, physical activity, and hydration status, as well as medical conditions such as thyroid disorders or the effects of certain medications. Because the measurement reflects overall body composition rather than a specific organ function, it provides a useful snapshot for monitoring health trends over time.

Continuous Glucose (CGM) is a smart‑metric that continuously monitors interstitial glucose levels to reflect real‑time blood sugar trends. Higher glucose readings can suggest insufficient insulin action, recent carbohydrate intake, stress, illness, or reduced physical activity, while lower readings may indicate effective insulin response, recent exercise, fasting, or medication effects such as insulin or sulfonylureas. Common drivers of glucose fluctuations include dietary composition, sleep quality, hydration status, and certain drugs, and the metric can be influenced by hormonal changes or acute illness. By tracking these patterns, users gain insight into how lifestyle and health factors impact their glucose control without making diagnostic or treatment claims.

Daily Step Count is a smart metric that tracks the total number of steps you take each day, offering a simple gauge of overall physical activity. Higher step counts generally suggest more movement and can be linked to better cardiovascular health, weight management, and mood, while lower counts may indicate a sedentary lifestyle, reduced fitness, or recovery from illness or injury. Common factors that influence daily steps include the amount of structured exercise, occupational demands, and environmental conditions such as weather or terrain. Tracking this metric can help you identify patterns, set realistic activity goals, and monitor progress toward a more active, healthier routine.

Deep Sleep (slow‑wave sleep) is a smart metric that quantifies the amount of restorative, high‑amplitude brain activity occurring during the deepest stage of sleep. Higher levels of slow‑wave sleep generally indicate better physiological recovery, supporting cardiovascular health, metabolic regulation, and immune function, while lower amounts can suggest insufficient rest, stress, or disruptions such as sleep apnea, shift work, or excessive alcohol consumption. Factors that commonly influence this metric include overall sleep duration, sleep hygiene, and lifestyle habits like caffeine intake or intense evening exercise. Because it is derived from wearable or polysomnographic data rather than a laboratory test, the metric reflects relative changes in an individual’s sleep architecture rather than an absolute diagnostic threshold.

Distance is a smart metric that totals how far a person travels on foot or in activity over a day, captured by a wearable's motion and GPS sensors. Higher daily distance generally reflects more movement and a more active lifestyle, supporting cardiovascular health and energy expenditure, while lower distance points to a more sedentary day or a recovery period. Common drivers include daily routine, structured exercise such as walking or running, occupation, and environmental factors like weather or terrain. Because it is sensor-estimated, it is most useful for tracking trends and setting movement goals rather than as a precise measurement, and it is not sex-specific.

The Fat‑to‑Muscle Ratio (FMR) is a smart metric that compares the amount of body fat to lean muscle mass, giving a single value that reflects body composition balance. A higher FMR indicates a relatively greater proportion of fat compared with muscle, which may suggest reduced metabolic efficiency, lower physical fitness, or increased risk of weight‑related health issues; a lower FMR signals more muscle relative to fat, often associated with better strength, higher resting metabolic rate, and improved functional capacity. Common factors that influence FMR include regular resistance training, overall activity level, dietary protein intake, and changes in body weight or hydration status.

Heart Rate Variability (HRV) measures the natural fluctuations in time between consecutive heartbeats, reflecting the balance between the sympathetic “fight‑or‑flight” and parasympathetic “rest‑and‑digest” branches of the autonomic nervous system. Higher HRV generally indicates a more adaptable, resilient cardiovascular system and better parasympathetic tone, while lower HRV suggests reduced flexibility, heightened stress, or underlying health issues. Common drivers of HRV include physical training load—regular exercise tends to raise HRV over weeks—and lifestyle factors such as sleep debt, dehydration, smoking, or acute illness, which can depress HRV temporarily. The metric is presented as a smart panel within the Cardiometabolic category and is not sex‑specific.

Lean Muscle Mass is a smart metric that estimates the amount of skeletal muscle in the body using data such as body composition analyses or wearable sensor inputs. Higher values generally indicate greater muscular development, which can suggest effective strength training, adequate protein intake, and overall good physical fitness, while lower values may reflect muscle loss due to inactivity, aging, illness, or insufficient nutrition. Common drivers of changes in this metric include variations in exercise intensity and frequency, dietary protein quality, sleep quality, and hormonal influences; acute factors such as recent injury or medication that affect muscle metabolism can also impact readings.

Light Sleep is a smart metric that measures the time spent in the lighter, non-REM stages of sleep that bridge wakefulness and deeper sleep, normally making up the largest share of a night's rest. It plays a role in memory processing and motor learning, and some light sleep is healthy and expected, so the goal is balance rather than minimizing it. A very high proportion of light sleep alongside little deep or REM sleep can suggest fragmented or less restorative rest, while a more even distribution across stages generally reflects good sleep architecture. Common drivers include total sleep duration, frequent awakenings, caffeine or alcohol, stress, and an irregular schedule. Because it is captured by a wearable rather than a lab test, it is best read alongside the other sleep stages and is not sex-specific.

Muscle Mass is a smart metric that quantifies the amount of contractile tissue in the body, reflecting overall muscular development. Higher values generally indicate greater strength and functional capacity, while lower values can suggest muscle loss due to inactivity, aging, illness, or inadequate nutrition. Conversely, unusually high muscle mass may result from intensive resistance training, anabolic medication use, or genetic predisposition. Factors such as regular strength‑training routines, protein intake, hormonal status, and recovery quality strongly influence this metric. Tracking changes over time helps gauge the effectiveness of fitness programs and identify potential health concerns related to muscle health.

Physical Activity is a smart metric that quantifies the amount and intensity of movement a person engages in throughout the day, often captured via wearable devices or self‑report tools. Higher scores generally suggest a more active lifestyle, which is linked to improved cardiometabolic health, better weight management, and enhanced mood, while lower scores may indicate sedentary behavior that can increase risk for heart disease, diabetes, and reduced functional capacity. Common drivers of the metric include daily routines, occupational demands, structured exercise programs, sleep quality, and overall energy levels; changes in health status, medication side effects, or periods of illness can also cause fluctuations.

Recovery Score (Readiness) is a smart metric that combines several overnight signals, such as heart rate variability, resting heart rate, respiratory rate, body temperature, and sleep quality, into a single daily number that reflects how well the body has recovered and how prepared it is for physical or mental strain. Higher scores generally indicate strong recovery, good autonomic balance, and readiness for harder training or a demanding day, while lower scores suggest accumulated fatigue, insufficient sleep, elevated stress, alcohol intake, or early illness. Common drivers include sleep duration and quality, recent training load, hydration, late meals or alcohol, travel, and psychological stress. Because it is calculated from multiple wearable inputs rather than a single sensor, the score is best interpreted as a trend over time rather than an absolute value, and it is not sex-specific.

Sleep Stages: REM is a metric that quantifies the amount of rapid eye movement sleep a person experiences, a phase associated with vivid dreaming and memory consolidation. Higher proportions of REM sleep often suggest adequate restorative recovery and can be linked to good mental health, while lower REM percentages may indicate stress, sleep fragmentation, or the influence of certain medications such as antidepressants. Factors that commonly affect REM levels include overall sleep duration, sleep debt, alcohol consumption, and circadian rhythm disruptions. Because this metric is presented as a smart metric rather than a lab value, the focus is on relative changes over time rather than fixed reference ranges.

Resting heart rate is the number of beats your heart beats per minute while you are at complete rest, typically measured after a period of inactivity. A lower resting heart rate generally reflects better cardiovascular fitness and efficient heart function, whereas a higher resting heart rate can suggest stress, poor conditioning, dehydration, illness, or the influence of certain medications such as stimulants. Common drivers of variation include recent physical activity, sleep quality, caffeine intake, and overall stress levels. Because this metric applies to all adults, no sex‑specific note is needed. Monitoring trends over time can help you gauge changes in fitness, recovery, and overall health status.

Sleep Consistency (bedtime and wake‑time variability) is a smart metric that measures how regularly a person goes to bed and wakes up each day. Higher variability—meaning large differences in bedtime or wake‑time—generally suggests poorer sleep regularity, which can be linked to increased cardiometabolic risk, heightened stress, and disrupted circadian rhythms; lower variability indicates a more consistent schedule, supporting better metabolic health and overall well‑being. Common drivers of increased variability include shift work, irregular social or leisure activities, and sleep debt, while stable routines, regular light exposure, and consistent daily habits tend to promote better consistency.

Sleep Efficiency is a smart metric that quantifies the proportion of time spent asleep while in bed, reflecting how well sleep is consolidated. Higher values indicate that a larger share of time in bed is spent sleeping, suggesting more restorative rest, whereas lower values suggest fragmented or insufficient sleep, which may be linked to factors such as stress, irregular sleep schedules, sleep disorders, or excessive caffeine intake. Common drivers of reduced efficiency include sleep debt, poor sleep hygiene, and certain medications that disrupt sleep architecture. Improving sleep environment, maintaining consistent bedtime routines, and managing stress can help enhance this metric.

Sleep Latency is a smart metric that measures how long it takes to fall asleep after getting into bed, also called sleep onset latency. A moderate latency of roughly ten to twenty minutes is generally considered healthy, while a long latency can reflect stress, caffeine, evening screen use, an irregular schedule, or insomnia, and a very short latency of just a few minutes can paradoxically signal significant sleep deprivation. Common drivers include stimulant intake, light exposure before bed, anxiety, inconsistent bedtimes, and accumulated sleep debt. Because it is measured by a wearable rather than in a lab, it is best interpreted as a trend over time alongside total sleep and sleep efficiency, and it is not sex-specific.

Sleep Score is a smart metric that summarizes overall sleep quality and quantity into a single, easy‑to‑understand number. Higher scores generally indicate better, more restorative sleep, while lower scores suggest fragmented or insufficient sleep that may leave you feeling fatigued or affect daily performance. Factors that commonly influence the score include total sleep duration, the proportion of deep versus light sleep, and disruptions such as frequent awakenings, irregular bedtime schedules, or environmental disturbances like noise and light. Lifestyle elements such as stress, caffeine intake, and exercise timing can also impact the metric, and chronic sleep debt or sleep‑related disorders may lead to persistently lower scores.

Total Calories is a smart metric that estimates the full amount of energy the body expends in a day, combining basal (resting) energy with active energy from movement and exercise. Higher totals generally reflect more physical activity layered on top of resting metabolism, while lower totals indicate a more sedentary day or a lower resting metabolic rate. The figure is shaped by body size, muscle mass, age, daily movement, and workout intensity, and wearable estimates rely on heart-rate and motion sensors, so they are approximations best used to track trends rather than exact intake-versus-output accounting. It is not sex-specific and pairs naturally with active calories and weight trends.

Total Sleep Duration is a smart metric that measures the overall amount of sleep an individual obtains over a given period, typically recorded in hours. Higher values generally indicate more sleep, which is often associated with better recovery, cognitive function, and metabolic health, while lower values can suggest insufficient rest, potentially contributing to fatigue, impaired glucose regulation, and increased cardiometabolic risk. Common drivers of reduced sleep include stress, irregular work schedules, excessive screen time before bed, and certain medications, whereas longer sleep may result from recovery periods after intense training, illness, or intentional sleep extension strategies. This metric is used within the Cardiometabolic panel to help assess lifestyle factors that influence overall health.

Cardiorespiratory fitness, measured as an estimated VO₂ max, reflects the maximum amount of oxygen your body can use during intense exercise and is a key indicator of overall aerobic capacity. Higher VO₂ max values generally suggest better heart and lung function, greater endurance, and a lower risk of cardiovascular disease, while lower values can indicate reduced fitness, possible deconditioning, or underlying health issues that limit oxygen delivery. Common factors that influence VO₂ max include regular aerobic training, which can improve the metric, and sedentary lifestyle, illness, or insufficient recovery, which can lower it. This smart metric does not provide a medical diagnosis but offers insight into how efficiently your body utilizes oxygen during physical activity.

Waist Circumference is a smart metric, usually entered from a tape measurement, that gauges the amount of fat stored around the abdomen, a stronger marker of cardiometabolic risk than body weight or BMI alone. A larger waist measurement is associated with greater visceral fat and higher risk of conditions such as type 2 diabetes, high blood pressure, and heart disease, while a smaller measurement generally reflects lower abdominal fat and risk. Common drivers include diet, physical activity, alcohol, sleep, stress, and hormonal changes, and tracking the trend over time gives a clearer picture of cardiometabolic progress than a single reading. Healthy reference ranges differ between men and women.

Weekly Exercise is a smart metric that summarizes how consistently someone completes planned intentional exercise across a typical week—often captured as number of workouts per week, minutes of moderate-to-vigorous activity, or goal completion (e.g., 150 minutes/week plus strength training). Higher weekly exercise volume and consistency are generally associated with better cardiometabolic fitness, lower resting heart rate and blood pressure, improved insulin sensitivity, healthier body composition, and lower long-term cardiovascular risk. Context matters: the best target depends on baseline fitness, age, injury history, and recovery capacity; very low weekly exercise can reflect time constraints or illness, while abrupt spikes can increase injury risk. Track trends over time and pair with recovery signals (sleep, soreness, HRV) to guide sustainable progress.

Weight is a smart metric that records total body mass, most reliably captured by a connected smart scale. On its own it reflects the sum of muscle, fat, water, and bone rather than body composition, so the trend over time matters far more than any single reading, since day-to-day changes are usually driven by hydration, food in the digestive tract, and time of day rather than real tissue change. A steady rise or fall over weeks can signal genuine changes in fat or muscle, fluid retention, or shifts in diet and training. Common drivers include caloric balance, hydration, sodium intake, training, and certain medications. It is not sex-specific and is best interpreted alongside body fat percentage and lean mass.

Workouts is a smart metric that captures discrete exercise sessions logged by a wearable, including the activity type, duration, calories burned, and heart rate response for each session. It differs from overall daily activity by isolating intentional training, so a higher frequency, duration, or intensity of sessions generally reflects a more consistent and demanding training routine, while fewer or lighter sessions indicate reduced structured exercise or a recovery period. Common drivers include training goals, schedule, fitness level, and how the heart responds to effort, and the data is most useful when reviewed alongside recovery and training load to keep effort and rest in balance. It is captured by a wearable and is not sex-specific.

Blood Oxygen (SpO₂) is a smart metric that estimates the percentage of hemoglobin in the blood that is carrying oxygen, typically measured by a finger oximeter or a wearable using optical sensors. In most healthy adults at sea level, readings are usually in the mid-to-high 90s%; lower or repeatedly dropping values can reflect issues such as sleep-disordered breathing (e.g., sleep apnea), respiratory illness, poor circulation, high altitude, or measurement artifact. Wearable SpO₂ is best used for trends—especially overnight patterns—because motion, cold fingers, poor sensor contact, nail polish, skin tone/algorithm limits, and device differences can affect accuracy. Persistent low readings or symptoms (shortness of breath, chest pain, confusion) should prompt clinical evaluation.

Respiratory Rate is a smart metric that measures the number of breaths taken per minute, most often recorded by a wearable during sleep when breathing is most stable. A healthy adult's rate stays within a fairly narrow personal range night to night, so a sustained rise above baseline can be an early signal of fever, infection, alcohol consumption, or physiological stress, while readings that hold steady generally reflect normal respiratory and recovery status. Common drivers of an elevated rate include illness, intense late-day exercise, high altitude, anxiety, and respiratory conditions, whereas consistent values suggest stable health. Because the most useful information comes from deviations against an individual's own baseline rather than a fixed normal range, this metric is tracked as a trend and is not sex-specific.

Temperature Deviation is a smart metric that tracks how far overnight body or skin temperature drifts from an individual's personal baseline, rather than reporting an absolute temperature. A positive deviation, meaning a warmer-than-usual reading, can reflect early illness or fever, alcohol intake, intense late-day exercise, a warm sleeping environment, or hormonal changes such as the luteal phase of the menstrual cycle, while readings close to baseline generally indicate stable health and good recovery. Common drivers include infection, inflammation, alcohol, heavy training, and ambient room temperature. Because the value is meaningful only relative to a person's own established baseline, it is interpreted as a trend over several nights and is not sex-specific, though it can complement cycle tracking in women.

Blood pressure, measured as systolic over diastolic, is a vital sign that reflects the force your heart generates to push blood through arteries. Higher values generally indicate increased strain on the cardiovascular system and a greater risk of heart disease, stroke, and kidney problems, while lower values suggest less stress on vessels but may signal under‑perfused organs if too low. Common drivers of elevated pressure include excess sodium intake, obesity, chronic stress, and certain medications, whereas regular aerobic exercise, weight loss, and a DASH‑style diet can help lower it. The metric applies to all adults and is used worldwide to guide prevention and management of cardiometabolic health.